AzPA Pharmacy Flash
Jan. 21, 2015

Nicotine Dependence Treatment Continuing Education & Certificate Program
AzPA
The University of Arizona HealthCare Partnership invites you to a great three-day CE program. Thursday, Feb. 12-Saturday, Feb. 14, enhance your clinical knowledge of tobacco intervention, and nicotine dependence treatment at the U of A campus in Tucson. Click here to download the registration form. More

Register for Southwestern Clinical Pharmacy Seminar
AzPA
Earn up to 12 CPEs with AzPA at the JW Marriott Tucson Feb. 21-22. This seminar will include sessions on drug updates, medication adherence, pharmacy law and more. More

Aetna: Medicare Part D update
AzPA
Aetna has decided to provide temporary access for Part D members to all pharmacies in the Aetna Premier Preferred network. Until at least Feb. 28, members will be able to have prescriptions filled at these pharmacies at in-network rates. Read the full letter from Terri Swanson, Vice President, Medicare Part D. More

The Arizona Partnership for Immunization
AzPA
The Arizona Partnership for Immunization is a nonprofit statewide public/private immunization coalition whose goal is to promote, educate and support Immunizations throughout the life span.

As part of our mission, TAPI produces and prints immunization materials available to providers, clinics, hospitals, our community etc. The materials are current, colorful, based on the Centers for Disease Control and Prevention recommendations and guidelines, and, best of all, are free. TAPI would be happy to provide your clinic with materials promoting flu immunizations, teen vaccines, and age-specific immunization schedules. Below are a few examples of TAPI materials.

Order materials at www.WhyImmunize.org/Free-Materials. The Free Materials tab is located at the top of the WhyImmunize.org webpage. Also, feel free to email KarinS@tapi.org with any materials questions. More

Register for Anticoagulation Certificate Program
AzPA
Become certified in anticoagulation management. Attend AzPA's comprehensive certificate program in Tucson this February. The program requires 14 hours of home study. Register today! More

Treating Hepatitis C: The big question no one is asking
By Jason Poquette
If 2014 will be remembered for anything, pharmaceutically speaking, it will probably be for the impact of the new oral Hepatitis C therapies that entered the market. It began at the tail end of 2013 when Gilead introduced their $1,000-per-pill HCV cure known as Sovaldi (sofosbuvir). This drug, soon accompanied by a few others, has proved to be a game-changer in this space. The introduction of these new oral therapies has raised many questions, but there is one big question that few people seem to be asking.More

Hospital-associated infections remain a concern
Pharmacy Times
Despite hospitals' improved infection controls, 1 out of every 25 patients contracts at least one infection during his or her stay, according to a U.S. Centers for Disease Control and Prevention report. More

Vaccine opponents often cluster in communities
HealthDay News
Parents who refuse to have their children vaccinated appear to be clustered in certain areas, a new study suggests. Among more than 150,000 children in 13 counties in Northern California, the researchers found five clusters where kids had missed one or more vaccinations by the time they were 3 years old.More

The coming revolution in much cheaper life-saving drugs
The Washington Post
Randy Hillard was supposed to be dead by now. In 2010, the Michigan State University psychiatry professor was diagnosed with stage four stomach cancer and given less than a year to live. He started wondering how he could die in the most comfortable way possible given the circumstances, even briefly researching an assisted-suicide organization in Switzerland.More

Study identifies potential for safer anti-inflammatory drugs
Medical News Today
For people with chronic inflammatory diseases, treatment with glucocorticoids — a class of steroid hormones — is common. While this medication may be effective for reducing inflammation, it can cause severe side effects when used long term. Now, researchers from Georgia State University say they may have identified a new way to suppress inflammation without the harmful side effects.More

Probiotics prevent respiratory infection in children
Pharmacy Times
Because upper respiratory tract infections cost $40 billion annually in the United States, even a small reduction in incidence would have significant economic consequences. More

1 in 10 patients inappropriately prescribed aspirin to prevent first heart attack, stroke
Medical News Today
More than 10 percent of patients in the U.S. receiving low-dose daily aspirin to prevent a first heart attack or stroke are likely to have been prescribed the medication inappropriately.More

Military pharmacies can get civilian prescriptions electronically
Military Times
Military pharmacies nationwide now may accept electronic prescriptions from civilian doctors, eliminating the need for paper or faxed scripts in many cases, according to Defense Health Agency officials. The transition to an electronic system called e-Rx began in early 2014 and is now available at clinic pharmacies in the U.S., Guam and Puerto Rico.More

Opium-soaked tampons, voodoo elixirs and leeches: Welcome to New Orleans' Pharmacy Museum
The Guardian
Located in the townhouse of the U.S.'s first licensed pharmacist, this lively, macabre, cringe-inducing museum provides a refreshing recontextualization of its many artifacts and an unflinching encounter with our mortality.More